PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies von Lee, J-m., Ledermann, J.A., Kohn, E.C.

Volltext

Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments von Ledermann, J.A., Canevari, S., Thigpen, T.

Volltext

PARP inhibitors in ovarian cancer von Ledermann, J A

Volltext

Front-line therapy of advanced ovarian cancer: new approaches von Ledermann, J A

Volltext

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up von Oaknin, A., Bosse, T.J., Creutzberg, C.L., Giornelli, G., Harter, P., Joly, F., Lorusso, D., Marth, C., Makker, V., Mirza, M.R., Ledermann, J.A., Colombo, N.

Volltext

Updated treatment recommendations for newly diagnosed epithelial ovarian carcinoma from the ESMO Clinical Practice Guidelines von Colombo, N., Ledermann, J.A.

Volltext

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Ledermann, J A, Raja, F A, Fotopoulou, C, Gonzalez-Martin, A, Colombo, N, Sessa, C

Volltext

ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer von Miller, R.E., Leary, A., Scott, C.L., Serra, V., Lord, C.J., Bowtell, D., Chang, D.K., Garsed, D.W., Jonkers, J., Ledermann, J.A., Nik-Zainal, S., Ray-Coquard, I., Shah, S.P., Matias-Guiu, X., Swisher, E.M., Yates, L.R.

Volltext

Latest clinical evidence and further development of PARP inhibitors in ovarian cancer von Mirza, M.R., Pignata, S., Ledermann, J.A.

Volltext

Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline von Sessa, C., Balmaña, J., Bober, S.L., Cardoso, M.J., Colombo, N., Curigliano, G., Domchek, S.M., Evans, D.G., Fischerova, D., Harbeck, N., Kuhl, C., Lemley, B., Levy-Lahad, E., Lambertini, M., Ledermann, J.A., Loibl, S., Phillips, K.-A., Paluch-Shimon, S.

Volltext

The systemic treatment of recurrent ovarian cancer revisited von Baert, T., Ferrero, A., Sehouli, J., O'Donnell, D.M., González-Martín, A., Joly, F., van der Velden, J., Blecharz, P., Tan, D.S.P., Querleu, D., Colombo, N., du Bois, A., Ledermann, J.A.

Volltext

Ovarian cancer von Jayson, Gordon C, Prof, Kohn, Elise C, MD, Kitchener, Henry C, Prof, Ledermann, Jonathan A, Prof

Volltext

Gastrostomy feeding in children with chronic kidney disease comes of age von Ledermann, Sarah E.

Volltext

Optimal first-line treatment in ovarian cancer von Raja, F A, Chopra, N, Ledermann, J A

Volltext

Targeted Therapies for Ovarian Cancer von Grunewald, Tami, BSc, MBBS, Ledermann, Jonathan A., BSc, MD, FRCP

Volltext

Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy von Gourley, Charlie, Balmaña, Judith, Ledermann, Jonathan A, Serra, Violeta, Dent, Rebecca, Loibl, Sibylle, Pujade-Lauraine, Eric, Boulton, Simon J

Volltext

Homologous recombination deficiency and ovarian cancer von Ledermann, Jonathan A, Drew, Yvette, Kristeleit, Rebecca S

Volltext

Estimating, Testing, and Comparing Specific Effects in Structural Equation Models: The Phantom Model Approach von Macho, Siegfried, Ledermann, Thomas

Volltext

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study von Matulonis, U.A., Shapira-Frommer, R., Santin, A.D., Lisyanskaya, A.S., Pignata, S., Vergote, I., Raspagliesi, F., Sonke, G.S., Birrer, M., Provencher, D.M., Sehouli, J., Colombo, N., González-Martín, A., Oaknin, A., Ottevanger, P.B., Rudaitis, V., Katchar, K., Wu, H., Keefe, S., Ruman, J., Ledermann, J.A.

Volltext

Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup... von Ruers, T., Punt, C., Van Coevorden, F., Pierie, J.P.E.N., Borel-Rinkes, I., Ledermann, J.A., Poston, G., Bechstein, W., Lentz, M.A., Mauer, M., Van Cutsem, E., Lutz, M.P., Nordlinger, B.

Volltext